OKYO logo

OKYO Pharma Limited (OKYO) Company Overview

Profile

Full Name:

OKYO Pharma Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

May 17, 2022

Indexes:

Not included

Website:

http://okyopharma.com

Description:

OKYO Pharma Limited is a biotechnology company focused on developing innovative treatments for eye diseases and other conditions. They aim to create new therapies using advanced science to improve patients' quality of life and address unmet medical needs in the healthcare market.

Key Details

Price

$1.33

Market Cap

$45.16 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.57(+6.56% YoY)

PE Ratio

-

Annual ROE

286.17%

Annual Debt To Equity

0.00

Beta

0.50

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Mar 29, 2024

Recent annual earnings:

Aug 15, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy
Feb 14, 25 HC Wainwright & Co.
Buy
Feb 10, 25 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 16, 24 HC Wainwright & Co.
Buy
Aug 27, 24 HC Wainwright & Co.
Buy
Jul 12, 24 HC Wainwright & Co.
Buy
Jul 11, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Jan 8, 24 HC Wainwright & Co.
Buy

Screeners with OKYO included

Growing Shares Outstanding
Best performing stocks last 3 months
Stocks above SMA 50
UK stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Biggest stock gainers today

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.33
OKYO price is $1.33

Price All-time High

$3.62
OKYO price is currently -63.24% below its historical high of $3.62

Price Analysts Target

$7.00
OKYO price is currently -80.99% lower than the consensus analysts' forecast

Price Most Recent Change

+5.61%
OKYO price was up +5.61% on Mar 6, 2025

Price YTD Change

+15.71%
OKYO price is up +15.71% since January 1st

Price 3-Year Change

-
OKYO price 3-year change is unknown

Market cap

Market Cap

$45.16 M
OKYO market capitalization is $45.16 million

Market Cap 3-Year Change

-
OKYO market capitalization 3-year change is unknown

Market Cap All-time High

$87.28 M
OKYO market capitalization is currently -48.26% below its historical high of $87.28 million

Market Cap Sector Rank

34.65%
OKYO market capitalization is higher than 34.65% of companies in Healthcare sector

Technical

Beta

0.50
OKYO beta is 0.50

200-day SMA

$1.15
OKYO price is currently +15.85% above its 200-day simple moving average

14-day RSI

75.92
OKYO 14-day relative strength index is 75.92

30-day Relative Volume

0.63
OKYO 30-day relative volume is 0.63

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
OKYO annual revenue value is unknown

Annual Revenue Analysts Estimate

-
OKYO annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
OKYO annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
OKYO annual revenue is unknown

Profit

Annual Gross Profit

-
OKYO annual gross profit value is unknown

Annual Gross Margin

-
OKYO annual gross profit margin value is unknown

Annual Operating Profit

-$15.75 M
OKYO annual operating income is -$15.75 million

Annual Operating Margin

-
OKYO annual operating profit margin value is unknown

Annual Net Income

-$16.83 M
OKYO annual net profit is -$16.83 million

Annual Net Margin

-
OKYO annual net profit margin value is unknown

EPS

Annual EPS

-$0.57
OKYO annual earnings per share is -$0.57

Annual EPS Analysts Estimate

-$0.38
OKYO annual earnings per share is currently +50.00% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+6.56%
OKYO annual earnings per share is up +6.56% year-on-year

Annual EPS Sector Rank

68.05%
OKYO annual earnings per share is higher than 68.05% of companies in Healthcare sector

ROA & ROE

Annual ROA

-1091.64%
OKYO annual return on assets is -1091.64%

Annual ROE

286.17%
OKYO annual return on equity is 286.17%

EBIT & EBITDA

Annual EBIT

-$15.75 M
OKYO annual earnings before interest & taxes is -$15.75 million

Annual EBITDA

-$15.75 M
OKYO annual EBITDA is -$15.75 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
OKYO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
OKYO price to earnings ratio is unknown

PB Ratio

PB Ratio

-6.25
OKYO price to book ratio is -6.25

PB Ratio Sector Rank

3.8%
OKYO price to book ratio is higher than 3.8% of companies in Healthcare sector

PS Ratio

PS Ratio

-
OKYO price to sales ratio value is unknown

PS Ratio Sector Rank

-
OKYO price to sales ratio is unknown

Enterprise value

Enterprise Value

$44.17 M
OKYO enterprise value is $44.17 million

Enterprise Value Sector Rank

38.83%
OKYO enterprise value is higher than 38.83% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
OKYO EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
OKYO EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.21
OKYO annual current ratio is 0.21

Annual Quick Ratio

-
OKYO annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
OKYO annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-14.95
OKYO annual interest coverage ratio is -14.95

Risk & Stability

Piotroski F-Score

-
OKYO piotroski f-score value is unknown

Altman Z-Score

-
OKYO altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.54 M
OKYO annual total assets is $1.54 million

Annual Non Current Assets

$3400.00
OKYO annual long term assets is $3400.00

Annual Current Assets

$1.54 M
OKYO annual total current assets is $1.54 million

Annual Cash & Cash Equivalents

$826.80 K
OKYO annual cash & cash equivalents is $826.80 thousand

Equity

Annual Book Value

-$5.88 M
OKYO annual book value is -$5.88 million

Annual Working Capital

-$5.88 M
OKYO annual working capital is -$5.88 million

Liabilities

Annual Total Liabilities

$7.42 M
OKYO annual total liabilities is $7.42 million

Annual Total Long Term Liabilities

$0.00
OKYO annual total long term liabilities is $0.00

Annual Current Liabilities

$7.42 M
OKYO annual total current liabilities is $7.42 million

Annual Accounts Payable

$6.13 M
OKYO annual accounts payable is $6.13 million

Debt

Annual Total Debt

$0.00
OKYO annual total debt is $0.00

Annual Total Debt 1-Year Change

-100%
OKYO annual total debt is down -100% year-on-year

Annual Long Term Debt

-
OKYO annual long term debt value is unknown

Annual Short Term Debt

-
OKYO annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$15.75 M
OKYO annual total expenses is $15.75 million

Annual Operating Expenses

$15.75 M
OKYO annual total operating expenses is $15.75 million

Annual Cost Of Goods Sold

-
OKYO annual cost of goods sold value is unknown

Annual SGA

-
OKYO annual SGA value is unknown

Annual D&A

$3900.00
OKYO annual depreciation & amortization is $3900.00

Annual Interest Expense

$1.05 M
OKYO annual interest expense is $1.05 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.49 M
OKYO annual cash flow from operations is -$9.49 million

Annual CFO 1-Year Change

-23.33%
OKYO annual cash flow from operations is down -23.33% year-on-year

Annual CFI

$0.00
OKYO annual cash flow from investing activities is $0.00

Annual CFI 1-Year Change

+100%
OKYO annual cash flow from investing activities is up +100% year-on-year

Annual CFF

$6.21 M
OKYO annual cash flow from financing activities is $6.21 million

Annual CFF 1-Year Change

-33.41%
OKYO annual cash flow from financing activities is down -33.41% year-on-year

Free CashFlow

Annual FCF

-$9.49 M
OKYO annual free cash flow is -$9.49 million

Annual FCF 1-Year Change

-23.23%
OKYO annual free cash flow is down -23.23% year-on-year

CAPEX

Annual CAPEX

-
OKYO annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
OKYO annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

APYX logo
Apyx Medical (APYX)
SPRO logo
Spero Therapeutics (SPRO)
ICCC logo
ImmuCell (ICCC)
VTVT logo
vTv Therapeutics (VTVT)
MODV logo
ModivCare (MODV)
ALRN logo
Aileron Therapeutics (ALRN)
Rein Therapeutics (RNTX)
IMRX logo
Immuneering (IMRX)
IMMX logo
Immix Biopharma (IMMX)

FAQ

  • What is the ticker symbol for OKYO Pharma Limited?
  • Does OKYO Pharma Limited pay dividends?
  • What sector is OKYO Pharma Limited in?
  • What industry is OKYO Pharma Limited in?
  • What country is OKYO Pharma Limited based in?
  • When did OKYO Pharma Limited go public?
  • Is OKYO Pharma Limited in the S&P 500?
  • Is OKYO Pharma Limited in the NASDAQ 100?
  • Is OKYO Pharma Limited in the Dow Jones?
  • When was OKYO Pharma Limited's last earnings report?
  • When does OKYO Pharma Limited report earnings?
  • Should I buy OKYO Pharma Limited stock now?

What is the ticker symbol for OKYO Pharma Limited?

The ticker symbol for OKYO Pharma Limited is NASDAQ:OKYO

Does OKYO Pharma Limited pay dividends?

No, OKYO Pharma Limited does not pay dividends

What sector is OKYO Pharma Limited in?

OKYO Pharma Limited is in the Healthcare sector

What industry is OKYO Pharma Limited in?

OKYO Pharma Limited is in the Biotechnology industry

What country is OKYO Pharma Limited based in?

OKYO Pharma Limited is headquartered in United Kingdom

When did OKYO Pharma Limited go public?

OKYO Pharma Limited's initial public offering (IPO) was on May 17, 2022

Is OKYO Pharma Limited in the S&P 500?

No, OKYO Pharma Limited is not included in the S&P 500 index

Is OKYO Pharma Limited in the NASDAQ 100?

No, OKYO Pharma Limited is not included in the NASDAQ 100 index

Is OKYO Pharma Limited in the Dow Jones?

No, OKYO Pharma Limited is not included in the Dow Jones index

When was OKYO Pharma Limited's last earnings report?

OKYO Pharma Limited's most recent earnings report was on Mar 29, 2024

When does OKYO Pharma Limited report earnings?

The next expected earnings date for OKYO Pharma Limited is Mar 28, 2025

Should I buy OKYO Pharma Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions